Cascades Inc. reports its unaudited financial results for the three-month period ended December 31, 2018. Sales of $1,196 million increased by $114 million, or 11%, compared to the same period last year. This was driven by a 13% increase in the Tissue segment reflecting volume improvements, and a more favourable sales mix, exchange rate and average selling price during the period, as the company said in the press release received by Lesprom Network.
Cascades generated an operating income before depreciation and amortization (OIBD) of $37 million in the 4Q 2018. This compared to the $104 million generated in the comparable period last year.
For the three-month period ended December 31, 2018 , Cascades posted a net loss of $65 million , or$0.69 per share, compared to net earnings of $57 million , or $0.60 per share in the same period of 2017. On an adjusted basis, the Corporation generated break even net earnings in the 4Q 2018, or $0.00per share, compared to net earnings of $13 million, or $0.14 per share, in the same period of 2017.
Founded in 1964, Cascades offers sustainable, innovative and value-added packaging, hygiene and recovery solutions.
